Market Overview:

The Crispr and Cas gene market deals with gene editing techniques that make use of the Crispr/Cas9 system. This system allows genetic material to be added, removed, or altered at particular locations in the genome. It has applications in cell line engineering, biopharmaceutical production, and gene therapy among others. Advantages include being relatively inexpensive, highly versatile, and more precise compared to earlier gene-editing methods.

Market key trends:

One of the key trends in the Crispr and Cas gene market is the development of Crispr-based therapies for diseases. Companies are conducting clinical trials to test therapies for conditions like cancer, genetic disorders, and infectious diseases using Crispr gene editing. Other areas witnessing active research include developing delivery methods like viruses and nanoparticles to efficiently deliver Crispr components into target cells and minimizing off-target effects which is important for safety. There is also work ongoing related to base editing which complements traditional Crispr to enable direct conversion of one base to another without double-strand DNA breaks. Such technology advancements are helping expand the potential of Crispr to treat numerous diseases.
Segment Analysis

The CRISPR and Cas gene market is segmented by product into enzymes, kits, services, vectors & gRNA, design tools and other consumables. The enzymes segment dominated the market in 2022 and is expected to continue its dominance over the forecast period. This is attributed to the wide usage of enzymes like nucleases for gene editing and regulating gene expression through CRISPR technology.

Key Takeaways

The Global Crispr And Cas Gene Market Size is expected to witness high growth, exhibiting a CAGR of 22% over the forecast period, due to increasing R&D investments in genome editing and rising demand for disease modeling.

Regional analysis

North America dominated the global market in 2022 and is expected to continue its dominance over the forecast period driven by high funding for biological and genome research and presence of key players in the region. Asia Pacific is expected to exhibit the fastest growth rate over the forecast period owing to growing genomics research and increasing government initiatives to support life sciences industry in emerging countries like China and India.

Key players

Key players operating in the CRISPR and Cas gene market are Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich), OriGene Technologies, Inc., New England Biolabs, Cellecta, Inc., Agilent Technologies, Inc., Applied StemCell, Inc., Synthego, Genscript, Mirus Bio LLC, Integrated DNA Technologies, Inc., and Mammoth Biosciences, Inc. Companies operating in this market are focusing on new product launches, strategic collaborations, and expansions to cater to the increasing demand and further strengthen their presence in the market.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it